Funding

Corsera Health

United States · Healthtech · Biotech

Develops preventive RNAi medicines for cardiovascular disease prediction and prevention

Visit corserahealth.comFunding history

Funding history

1 round · 1 with disclosed amounts
AnnouncedRoundAmountInvestors
Series A$80MForbion — Role not disclosedPopulation Health Partners — Role not disclosed

Investors

ForbionSeries APopulation Health PartnersSeries A

Coverage

Jan 7, 2026Corsera Health · Series A

Similar companies

Guoke Brain-ComputerBeijing startup developing non-invasive wearable brain-computer interfaces that combine brain-signal detection, decoding and neural modulation.Undisclosed · Seed
Pathos AIClinical-stage drug developer using AI to select therapeutic assets and guide oncology trials.$237M · Series E
Star TherapeuticsBiotechnology company discovering and developing antibody therapies for diseases with significant unmet need.$200M · Private financing
Sourcescorserahealth.com ↗